UnitedHealth Group Inc (UNH) to Issue Quarterly Dividend of $1.08 on September 24th

UnitedHealth Group Inc (NYSE:UNH) declared a quarterly dividend on Tuesday, August 13th, Zacks reports. Shareholders of record on Monday, September 16th will be given a dividend of 1.08 per share by the healthcare conglomerate on Tuesday, September 24th. This represents a $4.32 annualized dividend and a yield of 1.85%. The ex-dividend date of this dividend is Friday, September 13th.

UnitedHealth Group has raised its dividend payment by an average of 22.5% annually over the last three years and has raised its dividend annually for the last 9 consecutive years. UnitedHealth Group has a payout ratio of 34.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect UnitedHealth Group to earn $16.62 per share next year, which means the company should continue to be able to cover its $4.32 annual dividend with an expected future payout ratio of 26.0%.

Shares of UNH traded up $1.26 during mid-day trading on Wednesday, hitting $233.72. 2,034,820 shares of the company were exchanged, compared to its average volume of 3,499,143. The stock has a market cap of $218.61 billion, a price-to-earnings ratio of 18.15, a price-to-earnings-growth ratio of 1.23 and a beta of 0.62. UnitedHealth Group has a 1-year low of $208.07 and a 1-year high of $287.94. The company has a 50 day moving average of $241.45 and a 200-day moving average of $243.82. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The company had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. During the same period in the previous year, the firm posted $3.14 EPS. UnitedHealth Group’s revenue was up 8.0% compared to the same quarter last year. Research analysts anticipate that UnitedHealth Group will post 14.84 earnings per share for the current fiscal year.

Several analysts recently commented on the company. Morgan Stanley boosted their price target on UnitedHealth Group from $285.00 to $298.00 and gave the stock an “overweight” rating in a research report on Friday, July 12th. Royal Bank of Canada set a $311.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Raymond James raised their price objective on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a report on Friday, July 19th. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Finally, Credit Suisse Group set a $293.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $294.11.

In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $246.40, for a total value of $1,232,000.00. Following the sale, the director now owns 187,979 shares in the company, valued at $46,318,025.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of UnitedHealth Group stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the completion of the sale, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 19,000 shares of company stock valued at $4,758,720. 0.82% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: Float

Dividend History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.